Pursuing Breakthrough Solutions
for Devastating Neurological Diseases
PurMinds is a trailblazer, pursuing breakthrough solutions for devastating neurological diseases while setting the gold standards for research, development, and proven scientific methods to serve the psychedelic science community.
We champion accelerated research and development through a robust psychedelic strategy, utilizing advanced development pathways in our flagship neuroscience lab and compound production facility in Ontario, as well as our partner’s R&D facilities in Israel.
ANXIETY & DEPRESSION by 2027
DEMENTA DRUGS by 2027
Our Integrative Business Pillars
Neuroscience & Drug Development
Compound Supply & Standardization
Analytical Chemistry & Data Science
Strategic investment and partnership for enhanced targeted drug delivery
Through our partnership with Nextage Therapeutics (NXTG: TASE), PurMinds has access to a patented liposomal drug delivery system, which enables drugs to penetrate the Blood-Brain-Barrier (BBB). This allows for the delivery of significantly lower doses, while exhibiting negligible dissipation to areas outside the brain, protecting from unwanted side effects commonly associated with psychedelic compounds.
WHY CHOOSE US
ACCELERATED DRUG DISCOVERY ENGINE
● Industry differentiating neuronal screening technology
● In-vitro screening coupled with AI data engine
Hybrid model of wholly-owned pipeline of drug and API candidates plus partnerships with pharma and biotech
● 8+ Therapeutic candidate programs
● 2 molecules with Blood Brain Barrier Targeting Technologies – industry benchmark for delivery systems
● Robust patent strategy
FOCUSED THERAPEUTIC DISCOVERY THESIS
Alzheimer’s Disease, Vascular Dementia (stroke), ALS, Parkinson’s
● Major Depressive Disorder Anxiety and Depression
INDUSTRY LEADING SUPPLIER
● cGMP, Standardized sources of psychedelic compounds & formulations (natural and synthetic)
● Cross continental cGMP R&D and Manufacturing in Canada and Israel
● Risk-averse, conservative, experienced leadership team
● 50+ combined scientific team with 100+ years of experience
PurMinds’ collective expertise at executing an accelerated development strategy through all phases of drug development and commercialization will advance our global development programs and expand our drug and API candidate pipeline.
Contact us for an investor presentation or partnership opportunities, click Contact Us or email us at firstname.lastname@example.org